A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric K Rowinsky, MD
Uniphar Development, LLC
Study Director - Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope (site 107)
Duarte, California, United States
Recruiting - University of California at Irvine (site 101)
Orange, California, United States
Recruiting - Ucla Medical Center (site 117)
Santa Monica, California, United States
Not, yet, recruiting - Moffitt Cancer Center Magnolia Campus (site 123)
Tampa, Florida, United States
Recruiting - City of Hope - Chicago Cancer Center (site 128)
Zion, Illinois, United States
Recruiting - Norton Cancer Institute (site 115)
Louisville, Kentucky, United States
Recruiting - Ochsner Medical Center (site 120)
New Orleans, Louisiana, United States
Not, yet, recruiting - Karmanos Cancer Center (site 109)
Detroit, Michigan, United States
Recruiting - Masonic Cancer Center, University of Minnesota (site 116)
Minneapolis, Minnesota, United States
Recruiting - Comprehensive Cancer Centers of Nevada - Central Valley (site 124)
Las Vegas, Nevada, United States
Recruiting - Rutgers Cancer Institute of New Jersey (site 103)
New Brunswick, New Jersey, United States
Recruiting - Rosewell Park Comprehensive Cancer Center (site 114)
Buffalo, New York, United States
Not, yet, recruiting - Memorial Sloan Kettering Cancer Center (site 108)
New York, New York, United States
Recruiting - University Hospitals Cleveland Medical Center Seidman Cancer Center (site 111)
Cleveland, Ohio, United States
Recruiting - James Cancer Hospital and Solove Research Institute (site 119)
Columbus, Ohio, United States
Recruiting - Mercy Clinic (site 110)
Oklahoma City, Oklahoma, United States
Recruiting - University of Texas Southwestern Medical Center (site 104)
Dallas, Texas, United States
Recruiting - Fred Hutchinson Cancer Center Clinic (site 122)
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 May 2026
- Primary completion
- 31 Oct 2027
- Completion
- 31 Oct 2027
- Last update posted
- 1 Jul 2026
- Registered enrollment
- 480
- Registry id
- NCT07265674
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.